<DOC>
	<DOCNO>NCT00918892</DOCNO>
	<brief_summary>RATIONALE : Studying gene express sample tumor tissue patient cancer may help doctor identify biomarkers related cancer . PURPOSE : This research study look tumor tissue sample patient undergone surgery breast cancer .</brief_summary>
	<brief_title>Assessment Candidate Protein Expression Breast Cancer Specimens</brief_title>
	<detailed_description>OBJECTIVES : - To determine candidate gene display differential expression normal cancer breast tissue . OUTLINE : Previously collect breast cancer tissue sample ( paraffin embed block ) normal adjacent tissue use immunohistochemistry study expression candidate gene .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis breast cancer Tissue sample available Samples select base presence absence tumor receptor , ( i.e . ; estrogen , progesterone , HER2 receptor ) group follow 4 category : Estrogen receptor ( ER ) positive/progesterone receptor ( PR ) positive/HER2negative ERpositive/PRpositive/ HER2positive FISH ERnegative/PRnegative/HER2positive ERnegative/PRnegative/HER2negative ( triple negative basaltype cancer ) PATIENT CHARACTERISTICS : Menopausal status specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>breast cancer</keyword>
	<keyword>estrogen receptor-negative breast cancer</keyword>
	<keyword>estrogen receptor-positive breast cancer</keyword>
	<keyword>progesterone receptor-negative breast cancer</keyword>
	<keyword>progesterone receptor-positive breast cancer</keyword>
	<keyword>triple-negative breast cancer</keyword>
	<keyword>HER2-negative breast cancer</keyword>
	<keyword>HER2-positive breast cancer</keyword>
</DOC>